sulodexide sulodexide sulodexide, traded as aterina, is a highly purified mixture of glycosaminoglycans composed of heparan sulfate (80%) and dermatan sulfate (20%). sulodexideclinical dataahfs/drugs.cominternational drug namesroutes ofadministrationoral, subcutaneous, intravenous, intramuscularatc codeb01ab11 (who) identifiers iupac name glucurono-2-amino-2-deoxyglucoglucan sulfate cas number57821-29-1 ydrugbankdb06271 yunii75hgv0062ckeggd08547 y (verify) pharmacology the low molecular weight of both sulodexide fractions allows for extensive oral absorption compared to unfractionated heparin. the pharmacological effects of sulodexide differ substantially from other glycosaminoglycans and are mainly characterized by a prolonged half-life and reduced effect on global coagulation and bleeding parameters. due to the presence of both glycosaminoglycan fractions, sulodexide potentiates the antiprotease activities of both antithrombin iii and heparin cofactor ii simultaneously. uses clinically, sulodexide is used for the prophylaxis and treatment of thromboembolic diseases; however, recent research has also demonstrated the beneficial effects of sulodexide in animal models of reperfusion injury and the treatment of diabetic nephropathy. in combination with melatonin, sulodexide has been shown to be a viable treatment option for patients suffering from central or sensorineural tinnitus. there have also been positive results in treating tinnitus using sulodexide as a monotherapy. soludexide has also been effectively used in the treatment of chronic venous disease.